切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2008, Vol. 04 ›› Issue (04) : 325 -330. doi: 10.3760/cma.j.issn.1673-5250.2008.04.108

论著

血红蛋白氧合酶在妊娠期高血压疾病发病中的作用
何玉洁, 成要平   
  1. 山西医科大学第一医院(太原,030001)
  • 出版日期:2008-08-01

Study on the Role of Hemeoxygenase in the Pathogenesis of Hypertensive Disorder Complicating Pregnancy

Yu-jie HE, Yao-ping CHENG   

  1. Department of Obstetrics, the First Affiliated Hospital of Shanxi Medical University, Taiyuan 030001, China
  • Published:2008-08-01
引用本文:

何玉洁, 成要平. 血红蛋白氧合酶在妊娠期高血压疾病发病中的作用[J]. 中华妇幼临床医学杂志(电子版), 2008, 04(04): 325-330.

Yu-jie HE, Yao-ping CHENG. Study on the Role of Hemeoxygenase in the Pathogenesis of Hypertensive Disorder Complicating Pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2008, 04(04): 325-330.

目的

探讨血红蛋白氧合酶(hemeoxygenase,HO)的生理状态下主要存在形式血红蛋白氧合酶-1、血红蛋白氧合酶-2在妊娠期高血压疾病(hypertensive disorder complicating pregnancy)患者与正常晚孕妇女胎盘中的表达规律,以及其产物一氧化碳(carbon monoxide,CO)在外周血的变化,研究血红蛋白氧合酶在妊娠期高血压疾病发病中的作用。

方法

选取2005年5月至2005年12月在山西医科大学第一医院剖宫产分娩的56例孕妇为研究对象,采用原位杂交技术和免疫组化法检测30例妊娠期高血压疾病患者(观察组,其中,观察组A患者为8例,观察组B为22例)与26例正常晚孕妇女(对照组)胎盘组织中HO-1 mRNA,HO-2 mRNA的表达和定位,并应用血气仪检测外周血中碳氧血红蛋白(COHb)的变化。

结果

①HO-1 mRNA和HO-2 mRNA在观察组胎盘滋养细胞及血管内皮细胞中的表达与对照组比较,差异无显著意义(P>0.05)。②血红蛋白氧合酶-1在观察组胎盘滋养细胞中的表达,明显低于对照组,两组比较,差异有显著意义(P<0.05);血红蛋白氧合酶-2在观察组胎盘滋养细胞和血管内皮细胞中表达,均明显低于对照组,与对照组比较,差异有显著意义(P<0.05),并且随着妊娠期高血压疾病病情的加重,血红蛋白氧合酶-1和血红蛋白氧合酶-2表达逐渐减弱,与对照组比较,差异有显著意义(P<0.05)。③碳氧血红蛋白在观察组外周血中的水平明显低于对照组,两组比较,差异有显著意义(P<0.05)。

结论

血红蛋白氧合酶可能参与妊娠期高血压疾病的发生。

Objective

To examine the expression of hemeoxygenase(HO)-1 and hemeoxygenase-2 in placenta tissue and changes of its byproduct carbon monoxide(CO)in peripheral blood between patients with the hypertensive disorder complicating pregnancy and women with normotensive late pregnancy,so as to explore the role of hemeoxygenase in the pathogenesis of hypertensive disorder complicating pregnancy.

Methods

The expression and localization of HO-1 mRNA and HO-2 mRNA in placenta tissue of the hypertensive disorder complicating pregnancy(the test group, n=30; the test group A had 8 cases of slight hypertensive disorder complicating pregnancy,the test group B had 22 cases of severe hypertensive disorder complicating pregnancy)and normotensive late pregnancy(the control group, n= 26)were detected by in situ hybridization and immunohistochemistry. In addition, the level of carbon monoxide- hemoglobin(COHb)in peripheral blood was studied by medical-image measure system.

Results

①The expression of HO-1 mRNA and HO-2 mRNA in placental trophoblast cells and vascular endothelial cells in the test group had no significant difference compared with those in the control group(P>0. 05).②The expression of hemeoxygenase-1 in placental trophoblast cells had a significantly reduced in placenta from the test group, compared with the control group(P<0. 05). The expression of hemeoxygenase-2 in placental trophoblast cells and vascular endothelium cells were significantly lower than those in the control group(P<0.05). The expression of hemeoxygenase-1 and hemeoxygenase-2 protein in the test group A were significantly higher than those in the test group B(P<0.05).③The level of carbon monoxidehemoglobin in peripheral blood in the test group was significant lower than that in the control group(P<0.05).

Conclusion

The hemeoxygenase may be involved in the pathogenesis of the hypertensive disorder complicating pregnancy.

图1 正常妊娠组胎盘滋养细胞中HO-1的表达(DAB染色×400)
图2 子痫前期重度组胎盘滋养细胞中HO-1的表达(DAB染色×400)
图3 子痫前期重度组胎盘滋养细胞中HO-2的表达(DAB染色×400)
1 Le J.Obstetrics and gynecology, 6th edition. Beijing: People's Medical Publishing House, 2004,97-100.[乐杰主编.妇产科学.第6版.北京:人民卫生出版社,2004, 97-100.]
2 Cheng GM, Shi YF, Chen XR. Expression and tissue localization of hemeoxygenase in human placenta. Chin J Obstet Gynecol, 2003,38(9):534-537.[程国梅,石一复,陈晓端.血红蛋白氧合酶在正常妊娠绒毛和胎盘组织中的表达及定位.中华妇产科杂志,2003,38(9):534-537.]
3 Pileggi A, Molano RD, Berney T, et al. HO-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes,2001, 50(9):1983-1991.
4 Sato K, Balla J, Otterbein L, et al. Carbon monoxide generated by hemeoxygenase-1 suppresses the rejection of mouse to rat cardiac transplants.J Immunol,2001,166(6):4185-4194.
5 Zenclussen ML, Anegon I, Bertoja AZ, et al. Hemeoxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion.J Reprod Immunol, 2006, 69(1):35-52.
6 Lyall F,Barber A,Myatt L,et al. Hemeoxygenase expression in human placenta and placental bed implies a role in regulation of trophoblast invasion and placental function. FASEB J,2000,14(1):208-219.
7 Bainbridge SA,Farley A,Mclaughlin B,et al. Carbon monoxide decreases perfusion pressure in isolated human placenta. Placenta, 2002,23(8-9):563-569.
8 Vachharajani TJ,Work J,Issekutz AC, et al. Hemeoxygenase modulates selectin expression in different regional vascular beds. Am J Physiol Heart Circ Physiol, 2000,278(5):1613-1617.
9 McGeary RP, Szyczew AJ, Toth I.Biological properties and therapeutic potential of bilirubin. Mini Rev Med Chem, 2003,3(3):253-256.
10 Yang L, Quan S,Abraham NG. Retrovirus-mediated HO gene transfer into endothelial cells protects against oxidant-induced injury. Am J Physiol,1999,277(1):127-133.
11 Roberts JM, Lain KY. Recent insights into the pathogenesis of pre-eclampsia. Placenta, 2002,23(5):359-372.
12 Baum M,Schiff E,Kreiser D,et al. End-tidal carbon monoxide measurements in women with pregnancy-induced hypertension and preeclampsia. Am J Obstet Gynecol,2000, 83(4):900-903.
13 Kreiser D,Baum M,Seidman DS,et al. End tidal carbon monoxide levels are lower in women with gestational hypertention and pre-eclampsia.J Perinatol,2004,24(4):213-217.
14 Cudmore M,Ahmad S,Al-Ani B,et al. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation,2007,115(13):1789-1797.
15 Zenclussen ML, Anegon I,Bertoja AZ, et al. Hemeoxygenase-1 by adenoviral gene transfer improves pregnancy outcome in a murine model of abortion.J Reprod Immunol, 2006, 69(1):35-52.
[1] 魏宇婷, 罗红. 超声弹性成像评价胎儿生长受限的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 256-260.
[2] 冯丹艳, 曹晓辉, 史玉霞. 血清脂联素与胎盘亮氨酸氨肽酶对妊娠期糖尿病患者妊娠结局的影响[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 302-308.
[3] 匡德凤, 李志国, 华绍芳, 薛凤霞. 高脂诱导孕鼠血清及胎盘组织脂肪酸结合蛋白-4及相关脂蛋白水平变化及其意义[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(03): 338-344.
[4] 任国华, 杜晓晓, 洪善玲, 邵帅. 妊娠期高血压并发急性肾损伤患者血清白细胞介素-22、硫化氢及护骨素水平的变化与意义[J]. 中华肾病研究电子杂志, 2023, 12(03): 150-155.
[5] 吴晓翔, 杨波, 李景漩, 张凤玲, 郭桂辉, 郑少培. 脐动脉超声检查联合NLR、sFlt-1/PLGF对妊娠高血压综合征患者不良妊娠结局的预测价值[J]. 中华临床医师杂志(电子版), 2023, 17(03): 266-271.
[6] 中国医师协会妇产科分会母胎医学专委会, 中华医学会围产医学分会重症学组. 预防性介入治疗在胎盘植入性疾病的应用专家共识(2023)[J]. 中华产科急救电子杂志, 2023, 12(03): 133-140.
[7] 陈颖, 曾万江. 病理组织学诊断在胎盘植入性疾病中的作用和意义[J]. 中华产科急救电子杂志, 2023, 12(03): 143-146.
[8] 赵先兰, 周艳. 胎盘植入性疾病出血血管介入治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 147-150.
[9] 张丽姿, 陈敦金. 胎盘植入性疾病的不良结局及远期影响[J]. 中华产科急救电子杂志, 2023, 12(03): 155-158.
[10] 郭志荣, 马京梅. 胎盘植入性疾病的风险评估和治疗策略[J]. 中华产科急救电子杂志, 2023, 12(03): 151-154.
[11] 古士锋, 张丽姿, 梁景英, 杜丽丽, 孙雯, 陈敦金. 2011-2021年我国胎盘植入性疾病研究热点:基于CiteSpace可视化分析[J]. 中华产科急救电子杂志, 2023, 12(03): 159-166.
[12] 岳永飞, 朱利平, 王晓艳. 磁共振成像技术在预测胎盘植入性疾病患者剖宫产术中出血量的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 167-172.
[13] 王永, 李霞林, 杨蓉, 潘康妮, 余琳, 王伟伟, 孙雯, 陈敦金. 胎盘植入合并严重产后出血输血方案的研究[J]. 中华产科急救电子杂志, 2023, 12(03): 173-179.
[14] 吴文诗, 魏宋荃, 李桂民, 郑晓芳, 孙雯, 陈敦金, 余琳. 胎盘植入性疾病患者行子宫部分切除术后再次妊娠的临床研究[J]. 中华产科急救电子杂志, 2023, 12(03): 180-186.
[15] 陆晓勤, 刘先保, 龙尚乾, 宋可欣, 邓艳红, 张春芳. 不同程度胎盘植入患者剖宫产的麻醉决策及母婴结局[J]. 中华产科急救电子杂志, 2023, 12(03): 187-192.
阅读次数
全文


摘要